Pages that link to "Q40125733"

The following pages link to Vasopressin-prostaglandin interactions in the regulation of epithelial cell permeability to water (Q40125733):

Displaying 19 items.

• Controversies in heart failure. Are beneficial effects of angiotensin-converting enzyme inhibitors attenuated by aspirin in patients with heart failure? (Q28191697) (← links)
• Effects of low intensity infrared laser radiation on the water transport in the isolated toad urinary bladder (Q31138339) (← links)
• Urinary concentration: different ways to open and close the tap. (Q38111968) (← links)
• Prostaglandins and other arachidonic acid metabolites in the kidney (Q39588227) (← links)
• Diuretics. Clinical pharmacology and therapeutic use (Part I). (Q39814755) (← links)
• Mechanism of preservation of glomerular perfusion and filtration during acute extracellular fluid volume depletion. Importance of intrarenal vasopressin-prostaglandin interaction for protecting kidneys from constrictor action of vasopressin (Q40927387) (← links)
• Interactions between 8-L-arginine vasopressin and prostaglandin E2 in human mononuclear phagocytes (Q40983976) (← links)
• Regulatory volume decrease in a renal distal tubular cell line (A6). II. Effect of Na+ transport rate (Q41285983) (← links)
• Role of prostaglandin E2 in regulation of low and high water osmotic permeability in frog urinary bladder. (Q42438395) (← links)
• Mechanism for the 'anti-lipolytic' action of vasopressin in the starved rat. (Q42867690) (← links)
• Ca2+ entry through the apical membrane reduces antidiuretic hormone-induced hydroosmotic response in toad urinary bladder (Q44531074) (← links)
• Increased urinary excretion of PGE2 during inappropriate antidiuresis induced by DDAVP. (Q45280238) (← links)
• Efficacy of COX-2 inhibitors in a case of congenital nephrogenic diabetes insipidus (Q46766518) (← links)
• Treating lithium-induced nephrogenic diabetes insipidus with a COX-2 inhibitor improves polyuria via upregulation of AQP2 and NKCC2. (Q46794013) (← links)
• Therapeutic and diagnostic potential of a vasopressin-2 antagonist for impaired water handling in cirrhosis (Q47961515) (← links)
• Antagonism of V2-receptor effect of antidiuretic hormone by atrial natriuretic peptide in man (Q70055719) (← links)
• Inhibition of the antidiuretic hormone hydroosmotic response by phospholipids and phospholipid metabolites (Q70148703) (← links)
• Evidence for independent actions of vasopressin on renal inner medullary cyclic AMP and prostaglandin E production: Relationship of the prostaglandin E response to hormone pressor activity (Q72960996) (← links)
• The aspirin-angiotensin-converting enzyme inhibitor tradeoff: to halve and halve not (Q73858819) (← links)